A Dell-tested NVIDIA N1X laptop just resurfaced in a recent test record. It’s a solid hint Nvidia’s laptop processor plans ...
A new supply-chain leak has put Nvidia’s rumored N1X back on the radar, but it also highlights how little tangible progress ...
For years, the Apple TV 4K has occupied a curious space in the Cupertino ecosystem. It was the "hobby" that grew into the gold standard for streaming ...
Microsoft's latest Windows 11 test build is not about eye-catching features, it's about engineering. With the release of ...
Veteran ISRO scientist Dr S Venkateswara Sharma discusses the PSLV-C62 failure, the strategic importance of the EOS-N1 ...
The Nigerian Exchange (NGX) has extended its strong momentum into 2026, building on one of its most impressive rallies in ...
US investigators are still trying to understand why the UPS Boeing MD-11F involved in the fatal take-off crash at Louisville ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine ...
The Punch on MSN
NNPC subsidiaries’ debt balloons 70% to N30tn
NNPC subsidiary debt surged by 70% to N30.30tn in 2024, as revealed by audited financials. This sharp rise sparks concerns ...
C62, carrying the EOS-N1 Earth-observation satellite and a cluster of commercial payloads, deviated from its planned path ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m (1) TP).
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹?TP). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results